Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ballanti

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Mineral and Electrolyte Metabolism|January 1, 1994
Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable studyS Mazzaferro, M Pasquali, P Ballanti, et al.
Mineral and Electrolyte Metabolism|January 1, 1988
Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patientsM Gonella, P Ballanti, C Della Rocca, et al.
Calcified Tissue International|July 1, 1984
Bone loss after glucocorticoid therapyV Lo Cascio, E Bonucci, B Imbimbo, et al.
Mineral and Electrolyte Metabolism|January 1, 1991
Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failureG Coen, S Mazzaferro, P Ballanti, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1986
The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralizationS Costantini, E Bonucci, P Mocetti, et al.
Nephron|January 1, 1990
Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophyS Mazzaferro, G Coen, P Ballanti, et al.
Mineral and Electrolyte Metabolism|January 1, 1988
Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidismF Pizzarelli, P Ballanti, S Costantini, et al.
Bone|January 5, 2000
Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosteroneG Silvestrini, P Ballanti, F R Patacchioli, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|September 30, 1981
[Bone histomorphometry: methodological criteria in the study of metabolic skeletal diseases]G Coen, P Ballanti, M Taccone-Gallucci, et al.
Journal of Endocrinological Investigation|July 2, 2008
Trabecular bone microarchitecture in mild primary hyperparathyroidismL Dalle Carbonare, P Ballanti, F Bertoldo, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Mineral and Electrolyte Metabolism|January 1, 1994
Intravenous versus oral calcitriol therapy in renal osteodystrophy: results of a prospective, pulsed and dose-comparable studyS Mazzaferro, M Pasquali, P Ballanti, et al.
Mineral and Electrolyte Metabolism|January 1, 1988
Improved bone morphology by normalizing serum magnesium in chronically hemodialyzed patientsM Gonella, P Ballanti, C Della Rocca, et al.
Calcified Tissue International|July 1, 1984
Bone loss after glucocorticoid therapyV Lo Cascio, E Bonucci, B Imbimbo, et al.
Mineral and Electrolyte Metabolism|January 1, 1991
Plasma insulin-like growth factor-1 and bone formation parameters in predialysis chronic renal failureG Coen, S Mazzaferro, P Ballanti, et al.
Annali Dell'Istituto Superiore Di Sanita|January 1, 1986
The role of aluminium in experimental osteomalacia. Preliminary results: Aluminium content and bone mineralizationS Costantini, E Bonucci, P Mocetti, et al.
Nephron|January 1, 1990
Osteocalcin, iPTH, alkaline phosphatase and hand X-ray scores as predictive indices of histomorphometric parameters in renal osteodystrophyS Mazzaferro, G Coen, P Ballanti, et al.
Mineral and Electrolyte Metabolism|January 1, 1988
Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidismF Pizzarelli, P Ballanti, S Costantini, et al.
Bone|January 5, 2000
Evaluation of apoptosis and the glucocorticoid receptor in the cartilage growth plate and metaphyseal bone cells of rats after high-dose treatment with corticosteroneG Silvestrini, P Ballanti, F R Patacchioli, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|September 30, 1981
[Bone histomorphometry: methodological criteria in the study of metabolic skeletal diseases]G Coen, P Ballanti, M Taccone-Gallucci, et al.
Journal of Endocrinological Investigation|July 2, 2008
Trabecular bone microarchitecture in mild primary hyperparathyroidismL Dalle Carbonare, P Ballanti, F Bertoldo, et al.
Pageof 8